Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CheckMate 915: Opdivo and Yervoy vs Opdivo in Resected Stage III/IV Melanoma
NCT03068455Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2017
- Primary completion
- Jun 2020
- Modality
- Monoclonal Antibodies
- Countries
- 19
01
Overview
A Phase 3 trial of ipilimumab in melanoma, sponsored by Bristol Myers Squibb. Started Apr 2017; status: completed.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03068455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068455.